NERv Announces $1M CAD in Pre-Seed Round

Ontario Industry Updates
Written By Guest User
nervtechnologyinc.png

NERv Technology Inc., an innovative medtech venture co-founded by a number of University of Waterloo alumni, has secured $1 million CAD in pre-seed funding. In partnership with a number of physician angel-investors, a hospital, and Sunhope Capital VC, this recent round of funding will help to cover the costs associated with preclinical studies and further development of their flagship post-operative sensory platform product.

Guest User
Previous

RetiSpec Receives Award from Alzheimer's Drug Discovery Foundation (ADDF)
Next

Iris Technologies acquired by Accelera Medtech Canada